Global Energy Prize awarded to three scientists from China, USA and Russia
The Prize in the Conventional Energy category went to Jinliang He, chair of High Voltage Engineering Research Institute, professor at China's Tsinghua University. 'This honour not only recognises my work alone, but also the collective endeavor of great minds advancing sustainable energy supply. It illuminates a shared vision to power world safely and efficiently. I dedicate this honour toward bridging innovation and advanced technologies for ultra-high voltage transmission systems,' said Jinliang He.
For the first time in the history of the Prize, the award in the Non-Conventional Energy category was given to a woman, Yu Huang, professor and department head at the University of California, Los Angeles (USA). She will be awarded for innovations in the field of catalyst development, which significantly improve the profitability, durability and performance of fuel cells.
'I'm deeply honoured and truly humbled to receive this prestigious award. My group develops designer catalysts and we work to bridge the gap between discovery and deployment, turning new materials into working for energy conversion and storage. I have been fortunate enough to work with an extraordinary group of students, postdocs and collaborators. Their creativity and passion are making all of this possible,' said Yu Huang.
Russian scientist Vladislav Khomich, head of research at the Institute for Electrophysics and Electric Power of the Russian Academy of Sciences (RAS), won in the New Ways of Energy Application category. He will receive the Prize for outstanding contributions to the development, creation and fundamental research of plasma technologies and pulsed energy.
The names of the laureates of the Prize were selected from a shortlist of 15 scientists from 8 countries. A total of 90 submissions from 44 countries and territories across the world were included in the nomination cycle.
The Committee, headed by the Nobel Peace Prize Laureate Rae Kwon Chung, made the final decision.
'World science is facing global challenges, and it is no exaggeration to say that our ability to quickly solve them will define the future of civilisation. The biggest challenges include the transition to clean technologies for the production, storage and transmission of energy and the search for solutions that can effectively combat global climate change,' said Rae Kwon Chung.
Photo: https://mma.prnewswire.com/media/2727261/Global_Energy_Prize_2025.jpg
View original content to download multimedia: https://www.prnewswire.com/news-releases/global-energy-prize-awarded-to-three-scientists-from-china-usa-and-russia-302501385.html
SOURCE Global Energy Prize
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Alphamab Oncology Announces IND Application for Innovative PD-L1/αvβ6 Bispecific ADC JSKN022 was Officially Accepted by CDE
SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: announced that the Investigational New Drug (IND) application for JSKN022, an independently developed innovative bispecific antibody-drug conjugate (ADC) targeting PD-L1 and integrin αvβ6, has been officially accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). The Company plans to initiate a first-in-human (FIH) clinical study of JSKN022 for the treatment of advanced malignant solid tumors. JSKN022 is an innovative bispecific ADC developed in-house with Alphamab's proprietary glycan-specific conjugation platform. The molecule simultaneously targets and binds to both PD-L1 and integrin αvβ6 on the surface of tumor cells. After binding to either target, JSKN022 enters the lysosome through target-mediated endocytosis. The cleavable linker is specifically hydrolyzed by proteolytic enzymes such as cathepsin B, releasing cytotoxic topoisomerase I inhibitor (T01), which then induces apoptosis of PD-L1 and/or integrin αvβ6 positive tumor cells. In addition, the inhibitor can penetrate the cell membrane and enter the antigen-negative tumor cells to exert bystander effects. These combined effects can effectively inhibit the growth of tumor cells. At present, no ADC targeting integrin αvβ6 or PD-L1 has been approved for marketing worldwide, with all related investigational candidates remaining in clinical development stages. Preclinical data demonstrate that JSKN022 exhibits potent antitumor activity in both in vitro and in vivo models against tumor cells expressing integrin αvβ6 and/or PD-L1. JSKN022 will potentially bring in novelty in the therapeutic approach for cancers that are refractory or resistant to PD-1/PD-L1 inhibitors, including non-small cell lung cancer, head and neck squamous cell carcinoma, and colorectal cancer. This Phase I clinical study will evaluate the safety, tolerability, pharmacokinetics (PK)/pharmacodynamics (PD), and antitumor activity of JSKN022 in patients with advanced malignant solid tumors who have failed standard therapies, and determine the maximum tolerated dose (MTD) and/or recommended Phase II dose (RP2D). About JSKN022JSKN022 is a first-in-class ADC targeting both PD-L1 and integrin αvβ6. Based on independently developed Envafolimab, Alphamab integrates immuno-oncology (IO) mechanisms with ADC approaches. This novel drug molecule utilizes glycan-specific conjugation technology to enhance both stability and homogeneity. The topoisomerase I inhibitor T01 is site-specifically conjugated to antibodies via a cleavable linker, enhancing therapeutic efficacy. JSKN022 is expected to provide a novel therapeutic option for cancers that are refractory or resistant to PD-1/PD-L1 inhibitors. The IND application for the first-in-human clinical study of JSKN022 for the treatment of advanced malignant solid tumors has been accepted by CDE. About Alphamab OncologyAlphamab Oncology is an innovative biopharmaceutical company focusing on oncology therapeutics. On December 12, 2019, the Company was successfully listed on the Main Board of the Hong Kong Stock Exchange, trading under the stock code 9966. By leveraging its proprietary core technology platforms including single-domain antibodies, bispecific antibodies, glycan-specific conjugation, linker-payload, dual-payload antibody conjugation, and subcutaneous high concentration formulation for biologics, the Company has established a product portfolio with differentiated innovation and global competitiveness, covering cutting-edge areas such as antibody-drug conjugates (ADCs), bispecific antibodies, and single-domain antibodies. The Company has one product approved for marketing (Envafolimab, the world's first subcutaneously injectable PD-(L)1 inhibitor), which has made a significant breakthrough in the convenience and accessibility of cancer treatment. Additionally, the Company has multiple bispecific antibodies and bispecific ADCs in clinical stage, while rapidly advancing the preclinical pipeline prioritizing bispecific ADCs and dual-payload ADCs. Multiple strategic collaborations based on innovative products or technology platforms have been established with partners such as CSPC, ArriVent, and Glenmark. Our overarching mission is to make cancer manageable and curable by addressing unmet clinical needs in oncology. Alphamab Oncology is continuously dedicated to the development of effective, safe, and globally competitive anti-tumor drugs, delivering China-innovated cancer therapies to benefit patients worldwide. View original content: SOURCE Alphamab Oncology Sign in to access your portfolio
Yahoo
15 hours ago
- Yahoo
China is betting on a real-world use of AI to challenge U.S. control
SHANGHAI - As the United States and China vie for control over the future of artificial intelligence, Beijing has embarked on an all-out drive to transform the technology from a remote concept to a newfangled reality, with applications on factory floors and in hospitals and government offices. China does not have access to the most advanced chips required to power cutting-edge models due to restrictions from Washington and is still largely playing catch-up with Silicon Valley giants like OpenAI. But experts say Beijing is pursuing an alternative playbook in an attempt to bridge the gap: aggressively pushing for the adoption of AI across the government and private sector. (The Washington Post has a content partnership with OpenAI.) Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. 'In China, there's definitely stronger government support for applications and a clear mandate from the central government to diffuse the technology through society,' said Scott Singer, an expert on China's AI sector at the Carnegie Endowment for International Peace. By contrast, the U.S. has been more focused on developing the most advanced AI models while 'the application layer has been totally ignored,' he said. China's push was on full display in Shanghai at its World Artificial Intelligence Conference, which ran until Tuesday. Themed 'Global Solidarity in the AI Era,' the expo is one part of Beijing's bid to establish itself as a responsible AI leader for the international community. This pitch was bolstered by the presence of international heavyweights like Eric Schmidt, former CEO of Google, and Geoffrey Hinton, a renowned AI researcher often called the 'Godfather of AI.' During the event, Beijing announced an international organization for AI regulation and a 13-point action plan aimed at fostering global cooperation to ensure the technology's beneficial and responsible development. 'China attaches great importance to global AI governance,' Li Qiang, China's premier, said at the opening ceremony on Saturday. It 'is willing to share its AI development experience and technological products to help countries around the world - especially those in the Global South,' he said, according to an official readout. Just last week, President Donald Trump announced a competing plan in a bid to boost American AI competitiveness by reducing regulation and promoting global exports of U.S. AI technology. Washington has moved in recent years to restrict China's access to chips necessary for AI development, in part due to concerns about potential military applications of such models and degrading U.S. tech leadership. The Trump administration's approach to chip policy, however, has been mixed. Earlier this month, the White House reversed a previous ban on specific AI chips made by U.S. tech giant Nvidia being exported to China. This shift occurred amid trade negotiations between the world's two largest economies, which have been locked in an escalating tariff and export control war since Trump returned to the Oval Office earlier this year. There was nothing but excitement about AI in the vast expo center in Shanghai's skyscraper-rich Pudong district, where crowds entered gates controlled by facial recognition. Inside, thousands of attendees listened to panels stacked with Chinese government officials, entrepreneurs and international researchers, or watched demonstrations on using AI to create video games, control robotic movements and respond in real time to conversations via smartglasses. Chinese giants like Huawei and Alibaba and newer Chinese tech darlings like Unitree Robotics were there. DeepSeek was not present, but its name was spoken everywhere. The Hangzhou-based upstart has been at the forefront of Beijing's attempt to push the government use of AI since it released a chatbot model in January, prompting a global craze and driving home China's rapid AI advances. DeepSeek has been put to work over the last six months on a wide variety of government tasks. Procurement documents show military hospitals in Shaanxi and Guangxi provinces specifically requesting DeepSeek to build online consultation and health record systems. Local government websites describe state organs using DeepSeek for things like diverting calls from the public and streamlining police work. DeepSeek helps 'quickly discover case clues and predict crime trends,' which 'greatly improves the accuracy and timeliness of crime fighting,' a city government in China's Inner Mongolia region explained in a February social media post. Anti-corruption investigations - long a priority for Chinese leader Xi Jinping - are another frequent DeepSeek application, in which models are deployed to comb through dry spreadsheets to find suspicious irregularities. In April, China's main anti-graft agency even included a book called 'Efficiently Using DeepSeek' on its official book recommendation list. China's new AI action plan underscores this push, declaring that the 'public sector should take the lead in deploying applications' by embedding AI in education, transportation and health care. It also emphasizes a mandate to use AI 'to empower the real economy' and praises open-source models - which are more easily shared - as an egalitarian method of AI development. Alfred Wu, an expert on China's public governance at the National University of Singapore, said Beijing has disseminated a 'top-down' directive to local governments to use AI. This is motivated, Wu said, by a desire to improve China's AI prowess amid a fierce rivalry with Washington by providing models access to vast stores of government data. But not everyone is convinced that China has the winning hand, even as it attempts to push AI application nationwide. For one, China's sluggish economy will impact the AI industry's ability to grow and access funding, said Singer, who was attending the conference. Beijing has struggled to manage persistent deflation and a property crisis, which has taken a toll on the finances of many families across the country. 'So much of China's AI policy is shaped by the state of the economy. The economy has been struggling for a few years now, and applications are one way of catalyzing much-needed growth,' he said. 'The venture capital ecosystem in AI in China has gone dry.' Others point out that local governments trumpeting their usage of DeepSeek is more about signaling than real technology uptake. Shen Yang, a professor at Tsinghua University's school of artificial intelligence, said DeepSeek is not being used at scale in anti-corruption work, for example, because the cases involve sensitive information and deploying new tools in these investigations requires long and complex approval processes. He also pointed out that AI is still a developing technology with lots of kinks. 'AI hallucinations still exist,' he said, using a term for the technology's generation of false or misleading information. 'If it's wrong, who takes responsibility?' These concerns, however, felt far away in the expo's humming hallways. At one booth, Carter Hou, the co-founder of Halliday, a smartglasses company, explained how the lenses project a tiny black screen at the top of a user's field of vision. The screen can provide translation, recordings and summaries of any conversation, and even deploy 'proactive AI,' which anticipates questions based on a user's interactions and provides information preemptively. 'For example, if you ask me a difficult question that is fact related,' Hou said, wearing the trendy black frames, 'all I need to do is look at it and use that information and pretend I'm a very knowledgeable person.' Asked about the event's geopolitical backdrop, Hou said he was eager to steer clear of diplomatic third rails. 'People talk a lot about the differences between the United States and China,' he said. 'But I try to stay out of it as much as possible, because all we want to do is just to build good products for our customers. That's what we think is most important.' Kiki Lei, a Shanghai resident who started an AI video company and attended the conference on Sunday, seemed to agree with this goal. She said that Chinese AI products are easier to use than U.S. products because companies here really 'know how to create new applications' and excel at catering to, and learning from, the large pool of Chinese technology users. Robots, perhaps the most obvious application of AI in the real world, were everywhere at the conference - on model factory floors and in convenience stores retrieving soda cans, shaking disbelieving kids' hands, or just roaming the packed halls. At the booth for ModelBest, another Beijing-based AI start-up, a young student from China's prestigious Tsinghua University, who was interning at the company, demonstrated how a robot could engage with its surroundings - and charm its human interlocutors. Looking directly at the student, the robot described his nondescript clothing. 'The outfit is both stylish and elegant,' the robot continued. 'You have a confident and friendly demeanor, which makes you very attractive.' - - - Pei-Lin Wu in Taiwan contributed to this report. --- Video Embed Code Video: Robots ruled at the World Artificial Intelligence Conference in Shanghai, where China displayed its latest tech and AI innovation. Washington Post China correspondent Katrina Northrop reported from the event on July 26.(c) 2025 , The Washington Post Embed code: Related Content Pets are being abandoned, surrendered amid Trump's immigration crackdown The Post exposed this farmer's struggle. Then the USDA called. Kamala Harris will not run for California governor, opening door for 2028 run Solve the daily Crossword
Yahoo
a day ago
- Yahoo
National Science Foundation staff decry Trump's ‘politically motivated' cuts
Almost 150 workers from the National Science Foundation (NSF) have lambasted Donald Trump's cuts to the agency as 'politically motivated and legally questionable', joining colleagues at three other federal research agencies in warning that the administration is destroying innovation and sacrificing the US's position as a global scientific leader. The three-page dissent states the actions of the administration 'collectively amount to the systemic dismantling of a world-renowned scientific agency' and that they have been compelled to act because 'NSF employees are bound by their oath to uphold the Constitution.' The document condemns the decision as 'illegally' withholding $2.2bn of the $9bn budget appropriated by Congress for 2025 and the 'unlawful termination and threatened mass reductions' in the workforce, which has already seen more than 10% of the agency's staff dismissed. They also point to the termination of more than 1,600 active NSF grants 'using undisclosed criteria devised by the Department of Government Efficiency (Doge)' – the quasi-government agency set up by Trump's billionaire donor Elon Musk. Earlier this month, the Guardian reported on the unprecedented political interference being wielded by Doge which, together with the chaotic cuts, has already undermined the gold standard review process used by the NSF to support cutting-edge science, and was jeopardizing the future of US industries and economic growth. 'A covert and ideologically driven secondary review process by unqualified political appointees is now interfering with the scientific merit-based review system,' the letter states. The best public interest journalism relies on first-hand accounts from people in the know. If you have something to share on this subject you can contact us confidentially using the following methods. Secure Messaging in the Guardian app The Guardian app has a tool to send tips about stories. Messages are end to end encrypted and concealed within the routine activity that every Guardian mobile app performs. This prevents an observer from knowing that you are communicating with us at all, let alone what is being said. If you don't already have the Guardian app, download it (iOS/Android) and go to the menu. Select 'Secure Messaging'. SecureDrop, instant messengers, email, telephone and post See our guide at for alternative methods and the pros and cons of each. The NSF was created 75 years ago and until Trump took office for his second term had enjoyed bipartisan support. It is the only federal agency that funds fundamental research across all fields of science and engineering, and which over the years has contributed to major breakthroughs in organ transplants, gene technology, AI, smartphones, extreme weather warning systems, American sign language, cybersecurity and even the language app Duolingo. Trump's budget proposal calls for a 56% cut to the NSF budget for 2026, which if enacted 'would undermine US leadership in science, eliminate funding for over 250,000 researchers and students, and break bipartisan commitments made under the CHIPS and Science Act', the letter states. The NSF statement follows similar unprecedented dissent by hundreds of scientists and other staff at the National Institutes of Health (NIH), the Environmental Protection Agency (EPA), and most recently the Voyager Declaration from almost 300 current and former Nasa scientists including four astronauts. All have warned about the devastating impact of the administration's arbitrary and chaotic cuts to staff and research funds on the lives of Americans – now and in the future – in order to pay for tax cuts for the wealthy including Trump's billionaire donors. The NSF dissent is addressed to California member of Congress Zoe Lofgren, the top Democrat on the House science committee, who has repeatedly condemned Trump's assault on science. Only one employee, Jesus Soriano, president of the local chapter of the American Federation of Government Employees which represents two thirds of the NSF's unionized bargaining unit, included his name; 148 of the 149 signatories are anonymous due to fear of reprisals. The fear is well founded given that around 140 named signatories of the EPA 'declaration of dissent' were put on administrative leave, and Lee Zeldin, the climate change denier and EPA secretary, warned that there was a 'zero-tolerance policy for career bureaucrats unlawfully undermining, sabotaging, and undercutting' the current administration. It ends with a stark warning: 'NSF employees are committed to serving the American people through research, education, and innovation. But they cannot do so under fear, censorship, and institutional sabotage. Without immediate oversight and corrective action from Congress, one of our nation's greatest engines for scientific and technological advancement faces irreversible long-term damage. Put simply, America will forfeit its scientific leadership position to China and other rival nations.'
